The landscape of HIV prevention has undergone a profound transformation with significant advancements in medical interventions and a deeper understanding of how the virus spreads. These developments ...

MEXICO CITY — It’s been called the closest the world has ever come to a vaccine against the AIDS virus. The twice-yearly shot was 100% effective in preventing HIV infections in a study of women, and ...

Health experts say that while lenacapavir is a major advance in HIV prevention, the twice-yearly injectable drug does not ...

Jared Baeten, MD, PhD, discusses the significance of the PURPOSE 1 trial results, which found that lenacapavir for pre-exposure prophylaxis resulted in no new infections of HIV. How significant is it ...

A groundbreaking medical advancement could reshape the future of HIV prevention. In a landmark clinical trial, a twice-yearly injection of lenacapavir demonstrated an astonishing 96% effectiveness in ...

From March 2026, people at high risk of contracting HIV will be able to visit their local clinic every six months for an HIV-prevention jab. The treatment combines a Lenacapavir injection with a short ...

The number of new HIV infections has fallen over the years – it declined by 39% from 2010 to 2023. But HIV’s devastating impact on global health persists. In 2023, 1.3 million people acquired HIV – ...

While Health Minister, Dr Aaron Motsoaledi, is still to announce the date for the launch of the game changing HIV prevention ...

"Pre-exposure prophylaxis (PrEP) is the most important concept in the [HIV] prevention field today," Robert Grant told the Infectious Disease Society of America at their annual meeting in San Diego.

In the quest to overcome quality-of-life altering side effects linked to combination antiretroviral therapy (cART) in people with HIV, a team of Johns Hopkins researchers has developed a new way to ...

Lenacapavir, a twice-yearly injectable, offers a new HIV prevention method, improving adherence compared to more frequent regimens. Phase 3 trials showed lenacapavir's high efficacy in preventing HIV, ...